NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MysmA.10611.d: Alcohol dehydrogenase B

Target Characteristics

from organism: Mycobacterium smegmatis ATCC 700084 / mc(2)155
most recent status: cloned
center reference id: MysmA.10611.d
is community request: False
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

External Resources

Resource Reference ID
OrthoMCL: OG5_127257
PATRIC ID: fig|246196.19.peg.213
RefSeq: YP_884632.1
UniProt: A0QNZ4

Enzyme & Pathway Information

Pathway Pathway ID EC Number
ethanol degradation I ETOH-ACETYLCOA-ANA-PWY 1.1.1.1
mixed acid fermentation FERMENTATION-PWY 1.1.1.1
heterolactic fermentation P122-PWY 1.1.1.1
acetylene degradation (anaerobic) P161-PWY 1.1.1.1
superpathway of N-acetylneuraminate degradation P441-PWY 1.1.1.1
hexitol fermentation to lactate, formate, ethanol and acetate P461-PWY 1.1.1.1
D-camphor degradation P601-PWY 1.1.1.1
ethanolamine utilization PWY0-1477 1.1.1.1
L-tryptophan degradation V (side chain pathway) PWY-3162 1.1.1.1
L-tyrosine degradation III PWY3O-4108 1.1.1.1
superpathway of fermentation (Chlamydomonas reinhardtii) PWY4LZ-257 1.1.1.1
L-valine degradation II PWY-5057 1.1.1.1
L-leucine degradation III PWY-5076 1.1.1.1
L-isoleucine degradation II PWY-5078 1.1.1.1
L-phenylalanine degradation III PWY-5079 1.1.1.1
L-methionine degradation III PWY-5082 1.1.1.1
pyruvate fermentation to ethanol I PWY-5480 1.1.1.1
pyruvate fermentation to ethanol II PWY-5486 1.1.1.1
phenylethanol biosynthesis PWY-5751 1.1.1.1
acetoin degradation PWY-6028 1.1.1.1
serotonin degradation PWY-6313 1.1.1.1
acetaldehyde biosynthesis I PWY-6333 1.1.1.1
noradrenaline and adrenaline degradation PWY-6342 1.1.1.1
pyruvate fermentation to ethanol III PWY-6587 1.1.1.1
superpathway of Clostridium acetobutylicum solventogenic fermentation PWY-6594 1.1.1.1
superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation PWY-6604 1.1.1.1
ethanol degradation II PWY66-21 1.1.1.1
phytol degradation PWY66-389 1.1.1.1
salidroside biosynthesis PWY-6802 1.1.1.1
3-methylbutanol biosynthesis (engineered) PWY-6871 1.1.1.1
(S)-propane-1,2-diol degradation PWY-7013 1.1.1.1
pyruvate fermentation to isobutanol (engineered) PWY-7111 1.1.1.1
chitin degradation to ethanol PWY-7118 1.1.1.1
superpathway of anaerobic sucrose degradation PWY-7345 1.1.1.1
butanol and isobutanol biosynthesis (engineered) PWY-7396 1.1.1.1
dehydrodiconiferyl alcohol degradation PWY-7557 1.1.1.1

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MKTKGALLWE LNSPFKVDEI DLGDPVADEV QIRLHAAGMC HSDYHITTGA TPIGLPALGG HEGAGVVTKV GKNVTGIEEG DHVILAFIPA CGECPPCLKG FRSLCDRGAV LLGGKAIADG TSRIHAGSHE VSPMNLLGTF APYMTVHKDS VVKIDKDIPF ETAAIMGCAV PTGFGSATNV AQVQAGETVI IVGVGGIGMS ALQGAVISGA KQVIAIDPNE WKREQAVKFG ATHVYPTMAE AIAPVIDVTH GLMADKVIIA VGEMKGEYIE EALILTAKTG TCVVTGMGAM TDVDVKLNLF LFTMLQKTLK GNIFGGGSSH IETPRLAALY KSGLLNIDDM VTRTYKLEDI NSGYQDMLDG KNIRGVIKYD ESDW

NT Sequence
ATGAAGACCA AAGGCGCTCT GCTATGGGAA CTGAATTCGC CGTTCAAGGT CGACGAGATC GATCTGGGCG ACCCCGTCGC CGATGAGGTA CAGATCCGGC TGCACGCTGC CGGCATGTGC CATTCCGACT ACCACATCAC CACGGGCGCG ACGCCCATCG GACTGCCCGC GCTCGGCGGG CACGAGGGCG CCGGCGTCGT CACCAAGGTC GGCAAGAACG TCACGGGCAT CGAAGAAGGT GACCACGTCA TCCTGGCGTT CATCCCGGCG TGCGGTGAAT GCCCGCCGTG TTTGAAGGGT TTCCGCTCGC TGTGTGATCG CGGCGCGGTT CTGCTGGGCG GCAAGGCGAT CGCCGACGGC ACCAGCCGTA TCCACGCCGG CAGCCACGAG GTGTCGCCGA TGAACCTGCT CGGCACCTTC GCGCCGTACA TGACCGTGCA CAAGGACTCG GTCGTCAAGA TCGACAAGGA CATCCCGTTC GAGACCGCGG CCATCATGGG CTGCGCGGTG CCCACCGGCT TCGGTTCGGC CACCAACGTC GCGCAGGTGC AGGCCGGCGA GACCGTGATC ATCGTCGGCG TCGGCGGCAT CGGCATGAGC GCATTGCAGG GTGCGGTGAT CTCGGGCGCC AAGCAGGTCA TCGCGATCGA TCCGAACGAG TGGAAGCGCG AGCAGGCCGT CAAGTTCGGC GCCACGCACG TCTACCCCAC CATGGCAGAG GCCATCGCCC CCGTCATCGA CGTCACCCAC GGTCTGATGG CCGACAAGGT CATCATCGCC GTCGGCGAGA TGAAGGGCGA GTACATCGAA GAGGCGTTGA TCCTGACCGC CAAGACCGGC ACGTGTGTCG TGACCGGCAT GGGTGCGATG ACCGACGTCG ACGTCAAGCT CAACCTGTTC CTGTTCACGA TGTTGCAGAA GACCTTGAAG GGCAACATCT TCGGAGGCGG CAGCAGCCAC ATCGAGACCC CGCGGCTGGC AGCGCTCTAC AAGTCCGGCC TGCTCAACAT CGACGACATG GTCACCCGGA CCTACAAGCT CGAAGACATC AACTCCGGAT ACCAGGACAT GTTGGACGGC AAGAACATCC GTGGCGTCAT CAAGTACGAC GAGTCGGACT GG

© 2022 Seattle Children's Research Institute. All rights reserved.